Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> AMGEN Latest News

JUN 18, 2015 - Yahoo! News

A Must Read - Share

Amgen's cancer drug meets main goal in late-stage study

(Reuters) - Amgen Inc said its drug met the main goal of improving overall survival in metastatic colorectal cancer patients who have not responded to chemotherapy. The U.S. Food and Drug Administration approved Vectibix in 2006 as a standalone treatment for metastatic colorectal cancer. In 2014, the drug was approved to be used, along with chemotherapy drug Folfox, as a ...

Tags: Amgen's cancer drug meets main goal in late-stage study,  Amgen Latest News

JUN 18, 2015 - Yahoo! News

A Must Read - Share

Amgen's cancer drug meets main goal in a late-stage study

(Reuters) - Amgen Inc said its experimental cancer drug met its main goal of improving overall survival in patients with the third most common form of the disease. The drug, Vectibix, was evaluated in patients with colorectal cancer in a late-stage study, the drugmaker said in a statement on Thursday. (Reporting by Rosmi Shaji in Bengaluru; Editing by Savio D'Souza)

Tags: Amgen's cancer drug meets main goal in a late-stage study,  Amgen Latest News